REG.AX ASX
Regis Healthcare Limited
1W: -0.7%
1M: +5.2%
3M: -32.6%
YTD: -32.6%
1Y: -42.2%
3Y: +92.6%
5Y: +136.9%
A$4.40 ($3.06)
-0.03 (-0.68%)
Weekly Expected Move ±4.7%
A$4
A$4
A$4
A$5
A$5
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$1.3B
+16.5% ▲
5Y CAGR: +14.4%
Gross Profit
$153M
+7.9% ▲
5Y CAGR: +17.7%
Operating Income
$51M
-15.3% ▼
5Y CAGR: +25.4%
Net Income
$56M
+13.8% ▲
5Y CAGR: +22.8%
EPS (Diluted)
$0.18
+12.5% ▲
5Y CAGR: +22.1%
EBITDA
$107M
-55.4% ▼
5Y CAGR: +5.3%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $718M | $771M | $1.0B | $1.2B | $1.3B |
| YoY Growth | +4.7% | +7.5% | +31.4% | +13.7% | +16.5% |
| Cost of Revenue | $713M | $775M | $967M | $1.0B | $1.2B |
| Gross Profit | $5M | -$4M | $47M | $141M | $153M |
| Gross Margin | 0.7% | -0.5% | 4.7% | 12.3% | 11.4% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $41M | $73M | $80M | $979M | $102M |
| Operating Expenses | $41M | $73M | $80M | $1.1B | $102M |
| Operating Income | -$36M | -$76M | -$41M | $60M | $51M |
| Operating Margin | -5.0% | -9.9% | -4.0% | 5.2% | 3.8% |
| Interest Expense | $8M | $11M | $91M | $119M | $3M |
| Income Before Tax | -$55M | -$40M | -$28M | $71M | $84M |
| Tax Expense | -$16M | -$12M | -$7M | $22M | $28M |
| Net Income | -$39M | -$28M | -$21M | $49M | $56M |
| Net Margin | -5.4% | -3.7% | -2.1% | 4.2% | 4.1% |
| EPS (Diluted) | $-0.13 | $-0.09 | $-0.07 | $0.16 | $0.18 |
| EBITDA | $56M | $97M | $191M | $240M | $107M |
| Shares Outstanding | 301M | 301M | 301M | 304M | 303M |